The role social justice advocacy should play in medicine will be examined by Sally Satel, a practicing psychiatrist and lecturer at Yale University School of Medicine, in her talk, “Medicine in the Age of Social Justice Activism.”
A three-year, $4.5 million grant will support a three-pronged research project to map the brain circuits that contribute to mood shifts in bipolar disorder and help develop personalized therapies for the condition.
New York City’s mostly indoor cats easily caught SARS-CoV-2 during the first wave of the COVID-19 epidemic – and most were asymptomatic and were likely infected by their owners.
Cornell researchers have developed a powerful new biosensor that reveals, in unprecedented detail, how and where kinases – enzymes that control nearly all cellular processes – turn on and off inside living cells.
Prior exposure to coronaviruses that cause ordinary colds can boost the immune system’s ability to attack a vulnerable site on the COVID-19-causing coronavirus SARS-CoV-2, according to a study led by investigators at Weill Cornell Medicine.
In 2025, four companies with Cornell-originated technologies — SafetyStratus, Bactana Corporation, Guard Medical and Halo Labs — were acquired by global corporate partners, allowing Cornell technologies to reach broader markets.
John August, program director of healthcare labor relations at Cornell University’s School of Industrial and Labor Relations, says this policy chaos has profound impacts on healthcare workers who are the primary point of contact with patients.